TECH OUTLOOKOctober - 2019 19We support the healthcare, pharmaceutical, and biotechnology sectors by combining individual treatment recommendations with monitoring capabilitiesDr. Josef Scheibermedication errors, pharmaceutical risks, medical side-effects, unsuccessful procedures, and deaths. Not only pharma companies can offer the right treatment but also save tremendously on time and resources. BioVariance not only deduces the appropriate medication for patients but also supports preventive care. The company accelerates medical data analysis by utilizing publicly available metabolome, transcriptome, and genome data available in the multi-omics space. It feeds disease-specific therapeutic data into its machine learning engine consistently for accurate results. With such an approach, doctors and other medical professionals can diagnose the disease quickly and efficiently. A case in point: BioVariance collaborated with a pharma company that wanted to predict the onset of a particular disease as early as possible using biomarkers. By aggregating data through the analysis of saliva or blood samples, BioVariance distinguished biomarker differences between affected patients and healthy people, enabling the client to predict the outbreak of diseases and take preventive measures accordingly. BioVariance ensures that therapeutic procedures are improved to enhance medical treatment further. The company goes a step further in personalizing care through its Pillbox application for permanent monitoring and control of therapy. The application notifies patients to take medications at regular intervals as prescribed and increases the safety of therapeutic procedures through relevant `documentation aids' that support the course of treatments. Treading on the success of its personalized care and backed by a well-structured team of subject matter experts from software, data science, and clinical areas, BioVariance aspires to expand its global footprint. In the near future, the company can be expected to provide patients the access to precision medicine and relevant therapeutic processes. Since applying algorithms for therapeutic care is still unregulated, BioVariance aims to standardize its processes and make it available to pharma companies and physicians worldwide.
< Page 9 | Page 11 >